Raytherapeutics
2 known investors
Ray Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology. The company focuses on addressing unmet patient needs in ophthalmology through gene therapy innovation.
Founders & leadership
PB
Paul BresgeCo-founder & Chief Executive Officer
Investors · 2
Frequently asked questions
- What does Raytherapeutics do?
- Ray Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology. The company focuses on addressing unmet patient needs in ophthalmology through gene therapy innovation.
- Who founded Raytherapeutics?
- Raytherapeutics was founded by Paul Bresge.
- Who are Raytherapeutics's investors?
- Raytherapeutics's investors include Norwest Venture Partners, Novo Holdings.